“HIV Clinic-based Extended-release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: a Non-blinded, Randomized Non-inferiority Trial”, Addiction, vol. 117, no. 7, pp. 1961-1971, 2022.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Denver, Colorado, 2021.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.”, Transl Vis Sci Technol, vol. 10, no. 3, p. 31, 2021.
, “Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)”, in Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
, “Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study.”, JMIR Res Protoc, vol. 9, no. 10, p. e20417, 2020.
, “Prevalence of obesity among U.S. population with substance dependence.”, Drug Alcohol Depend, vol. 217, p. 108293, 2020.
, , “Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).”, Implement Sci, vol. 14, no. 1, p. 48, 2019.
, “Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.”, Am J Med Genet C Semin Med Genet, vol. 181, no. 4, pp. 571-581, 2019.
, “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
, “Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.”, JAMA, vol. 316, no. 2, pp. 156-70, 2016.
, “Hair analysis and its concordance with self-report for drug users presenting in emergency department.”, Drug Alcohol Depend, vol. 167, pp. 149-55, 2016.
, “Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome.”, Front Pediatr, vol. 3, p. 49, 2015.
, “Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.”, J Glob Drug Policy Pract, vol. 6, no. 1, 2012.
, , “Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.”, Trials, vol. 12, p. 206, 2011.
, “SCORE Study Report 8: Closed Tests for All Pair-Wise Comparisons of Means.”, Drug Inf J, vol. 44, no. 4, pp. 405-420, 2010.
, “Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.”, AIDS Res Hum Retroviruses, vol. 21, no. 1, pp. 68-81, 2005.
, “Standardization and validation issues of the ELISPOT assay.”, Methods Mol Biol, vol. 302, pp. 51-86, 2005.
,